Health News Archive - June 14, 2005
Microsoft Corp founder Bill Gates is putting his financial muscle behind a campaign to get life-saving cervical cancer vaccines to women in poor countries.
Osman and colleagues at Saint Louis University are pushing for national changes in the way PET imaging scans are performed after determining that as much as 8 percent of cancerous legions occur outside of the current imaging field.
Expert from The Children's Hospital of Philadelphia comments on blood test for malignant hyperthermia.
A Marshfield Clinic scientist is searching for genetic and environmental causes of Alzheimerâ€™s disease as a first step toward developing diagnostic markers to identify people at risk before they develop the disease.
Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions.
A promising new drug candidate that may be effective against both actively dividing and slow-growing Mycobacterium tuberculosis (M. tb) has begun testing in humans, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced today.
Insight study reveals leading research on the benefits of using insulin earlier.
International Speech Communication Association (ISCA) workshop on plasticity in speech perception held by UCL at Beverage Hall, Senate House, June 15th - 17th.
Canada's universal health care plan is designed to provide equal access to care, independent of the patient's income level. A study in Health Services Research examined this issue, looking at patients with conditions for which timely care in doctors'offices has traditionally been thought to prevent expensive hospitalization for more serious consequences.
â€œPositron Emission Topography with choline demonstrates greater efficiency in the early diagnosis of relapsed prostate cancer with respect to other imaging techniquesâ€, stated Dr. Macarena RodrÃguez, of the Nuclear Medicine Service at the University.
- A transitional zone between two communities containing the characteristic species of each.